No Detail Found!

Anti-Cancer Effect of Cephalexin Loaded on Nano chitosan Against Humane Liver Cancer

Author(s)
Zahraa Ayad Ali Department of Biology-College of Education for Pure Sciences. University of Kerbala.,Karbala-,Iraq
Zainab Nizar Jawad Department of Biology-College of Education for Pure Sciences. University of Kerbala. Karbala-Iraq; Department of Optical Techniques, Al-Zahrawi University College, Karbala, Iraq.
Abstract
A beta-lactam antibiotic, such as cephalexin, is frequently prescribed to treat bacterial infections. In a particular investigation, cephalexin's effectiveness was assessed when it was administered ex vivo, or outside of a living organism, to the HepG2 human liver cancer cell line subsequent to its loading onto Nano chitosan. The purpose of the study was to determine how useful cephalexin would be in this situation. Positive study results showed that the drug worked well in this particular application. The ability of cephalexin to activate p53, a protein that is essential for starting the process of programmed cell death in liver cancer cells, was discovered. This shows that cephalexin, especially in combination with Nano chitosan, may be useful in the treatment of liver cancer. Overall, the study showed that cephalexin has the ability to target liver cancer cells and activate pathways that may result in their demise. Nevertheless, more investigation and clinical testing would be required to properly evaluate the safety and effectiveness of using cephalexin in this situation.
Publication Details
Page(s) 15-17
Published Journal: Journal of Pioneering Medical Sciences, Volume: 13, Issue: 2, Year: 2024

Request the full text from PASTIC

Keywords
Liver Cancer, cephalexin, nano chitosan
References
Yu L.,Wei J.,Liu P. .2022 .Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Seminars in Cancer Biology, 85 : 69-94.
Al-Mudhaffer R. H.,Ahjel S. W.,Hassan S. M.,Mahmood A. A.,Hadi N. R. .2020 .Age distribution of clinical symptoms, isolation, comorbidities and case fatality rate of COVID-19 cases in Najaf City, Iraq. Medical Archives, 74(5) : 363-367.
Jawad Z. N.,Abd K. I.,AL-Ghanimi B. K.,Al-Baiati M. N. .2023 .Using A Novel Nano Chitosan-Ampicillin Drug to Study the Effective Range of Drug Level Outside the Affected Cells. HIV Nursing, 23(2) : 953-956.
Khandekar A.,Vangara R.,Barnes M.,Díaz-Gay M.,Abbasi A.,Bergstrom E. N.,Alexandrov L. B. .2023 .Visualizing and exploring patterns of large mutational events with SigProfilerMatrixGenerator. BMC Genomics, 24(1) : 469.
Ahmadian E.,Janas D.,Eftekhari A.,Zare N. .2022 .Application of carbon nanotubes in sensing/monitoring of pancreas and liver cancer. Chemosphere, 302 : 134826.
Danylova T. V.,Komisarenko S. V. .2020 .Standing on the shoulders of giants: James watson, francis crick, maurice wilkins, rosalind franklin and the birth of molecular biology. Ukrainian Biochemical Journal, 92(4) : 154-165.
Hassan S. M.,Obeid H. A.,Hasan I. S.,Abbas A. N. .2023 .Etanercept ameliorated cerebral damage during global cerebral ischemiareperfusion injury in male rats. Azerbaijan Pharmaceutical and Pharmacotherapy Journal, 22(1) : 53-58.
Sangnim T.,Dheer D.,Jangra N.,Huanbutta K.,Puri V.,Sharma A. .2023 .Chitosan in oral drug delivery formulations: A review. Pharmaceutics, 15(9) : 2361.
Chen L.,Wei X.,Gu D.,Xu Y.,Zhou H. .2023 .Human liver cancer organoids: Biological applications, current challenges, and prospects in hepatoma therapy. Cancer Letters, 555 : 216048.
Fawaz S.,Merzouk M.,Barton S.,Nabhani-Gebara S. .2021 .Stability of amoxicillin and clavulanic acid in separate containers for administration via a y-site. In Drug Design, Development and Therapy, 15 : 3979-3984.
Xu P.,Xi Y.,Wang P.,Luka Z.,Xu M.,Tung H. C.,Xie W. .2022 .Inhibition of p53 sulfoconjugation prevents oxidative hepatotoxicity and acute liver failure. Gastroenterology, 162(4) : 1226-1241.
Al-Ziaydi A. G.,Al-Shammari A. M.,Hamzah M. I.,Kadhim H. S.,Jabir M. S. .2020 .Hexokinase inhibition using D-Mannoheptulose enhances oncolytic newcastle disease virus-mediated killing of breast cancer cells. Cancer Cell International, 20 : 1-10.
Al-Musawi S.,Albukhaty S.,Al-Karagoly H.,Sulaiman G. M.,Jabir M. S.,Naderi-Manesh H. .2020 .Dextran-coated superparamagnetic nanoparticles modified with folate for targeted drug delivery of camptothecin. Advances in Natural Sciences: Nanoscience and Nanotechnology, 11(4) : 045009.
Abbas Z. S.,Sulaiman G. M.,Jabir M. S.,Mohammed S. A.,Khan R. A.,Mohammed H. A. .2021 .Galangin/β -Cyclodextrin Inclusion Complex as a Drug-Delivery System for Improved Solubility and Biocompatibility in Breast Cancer Treatment. Molecules, 27(14) : 4521.
Ibrahim A. A.,Kareem M. M.,Al-Noor T. H.,Al-Muhimeed T.,AlObaid A. A.,Albukhaty S.,Sahib U. I. .2021 .Pt (II)- thiocarbohydrazone complex as cytotoxic agent and apoptosis inducer in Caov-3 and HT-29 Cells through the P53 and caspase-8 pathways. , 14(6) : 509.
Yashaswee S.,Trigun S. K. .2020 .Cytotoxicity and Induction of Apoptosis in Melanoma (MDA-MB-435S) Cells by Emodin. Journal of Scientific Research, 64(02) : 158-166.
Jawad Z. N. .2023 .Molecular detection of caspase 3, 8, 9 genes and ADIPOR1 (rs2275738) polymorphism in colorectal cancer. Applied Nanoscience (Switzerland), 13(8) : 5365-5368.
Centonze M.,Conza Di,Lahn G.,Fabregat M.,Dituri I.,Gigante F.,Serino I.,Scialpi G.,Carrieri R.,Negro L.,Pizzuto R.,Giannelli E.,G. E. .2023 .Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models. Journal of Experimental & Clinical Cancer Research, 42(1) : 211.
0

Citations

0

Downloads

58

Views